Professor Claire Wainwright

Wong, Matthew D., Lim, Adeline Y.L., Douglas, Tonia A. and Wainwright, Claire E. (2022). Cystic Fibrosis Cellular Treatments. Encyclopedia of Respiratory Medicine. (pp. 161-178) edited by Sam M. Janes. London, United Kingdom: Academic Press. doi: 10.1016/b978-0-08-102723-3.00110-4

Bye, Peter, Moriarty, Carmel, Sawyer, susan and Wainwright, Claire (2008). Outpatient care. Cystic fibrosis standards of care, Australia 2008. (pp. 31-36) edited by Dominic A. Fitzgerald. North Ryde, Sydney, NSW: Cystic Fibrosis Australia.

Reid, David and Wainwright, Claire (2008). Outreach Services and Clinics. Cystic fibrosis standards of care, Australia 2008. (pp. 51-54) edited by Dominic A. Fitzgerald. North Ryde, N.S.W.: Cystic Fibrosis Australia.

Wainwright, Claire and Wootton, Richard (2005). Asthma and Telemedicine. Monitoring Asthma: Volume 207. (pp. 107-122) CRC Press. doi: 10.1201/b14271-9

Wainwright, Clare E. and Wooton, R. (2005). Asthma and telemedicine. Monitoring asthma. (pp. 107-119) edited by Peter G. Gibson. Boca Raton, U.S.: Taylor & Francis.

Hisert, Katherine B, Birket, Susan E, Clancy, John Paul, Downey, Damian G, Engelhardt, John F, Fajac, Isabelle, Gray, Robert D, Lachowicz-Scroggins, Marrah E, Mayer-Hamblett, Nicole, Thibodeau, Patrick, Tuggle, Katherine L, Wainwright, Claire E and De Boeck, Kris (2023). Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy. The Lancet Respiratory Medicine, 11 (10), 916-931. doi: 10.1016/S2213-2600(23)00324-7

Robinson, Paul D, Douglas, Tonia A and Wainwright, Claire E (2023). Reducing treatment burden in the era of CFTR modulators. The Lancet Respiratory Medicine, 11 (9), e78-E78. doi: 10.1016/s2213-2600(23)00223-0

Wainwright, Claire, McColley, Susanna A., McNally, Paul, Powers, Michael, Ratjen, Felix, Rayment, Jonathan H., Retsch-Bogart, George, Roesch, Erica, Ahluwalia, Neil, Chin, Anna, Chu, Chenghao, Lu, Mengdi, Menon, Prema, Waltz, David, Weinstock, Tanya, Zelazoski, Laura, Davies, Jane C. and for the VX19-445-107 Study Group (2023). Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ≥6 Years with Cystic Fibrosis and At Least One F508del Allele: A Phase 3, Open-Label Clinical Trial. American Journal of Respiratory and Critical Care Medicine, 208 (1), 68-78. doi: 10.1164/rccm.202301-0021oc

Wainwright, Claire E. (2023). Airway inflammation and lung function in cystic fibrosis. Respirology, 28 (6), 509-510. doi: 10.1111/resp.14513

Zhang, Linjie, Mendoza-Sassi, Raúl Andrés, Wainwright, Claire E., Aregbesola, Alex and Klassen, Terry P. (2023). Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database of Systematic Reviews, 2023 (4) CD006458, 1-82. doi: 10.1002/14651858.cd006458.pub5

Acaster, Sarah, Mukuria, Clara, Rowen, Donna, Brazier, John E., Wainwright, Claire E., Quon, Bradley S., Duckers, Jamie, Quittner, Alexandra L., Lou, Yiyue, Sosnay, Patrick R. and McGarry, Lisa J. (2023). Development of the Cystic Fibrosis Questionnaire-Revised-8 dimensions: estimating utilities from the Cystic Fibrosis Questionnaire-Revised. Value in Health, 26 (4), 567-578. doi: 10.1016/j.jval.2022.12.002

Szczesniak, Rhonda, Andrinopoulou, Eleni-Rosalina, Su, Weiji, Afonso, Pedro M, Burgel, Pierre-Régis, Cromwell, Elizabeth, Gecili, Emrah, Ghulam, Enas, Goss, Christopher H, Mayer-Hamblett, Nicole, Keogh, Ruth H, Liou, Theodore G, Marshall, Bruce, Morgan, Wayne J, Ostrenga, Joshua S, Pasta, David J, Stanojevic, Sanja, Wainwright, Claire, Zhou, Grace C, Fernandez, Gabriela, Fink, Aliza K and Schechter, Michael S. (2023). Lung function decline in cystic fibrosis: impact of data availability and modeling strategies on clinical interpretations. Annals of the American Thoracic Society, 20 (7), 958-968. doi: 10.1513/annalsats.202209-829oc

Burke, Andrew, Thomson, Rachel M., Wainwright, Claire E. and Bell, Scott C. (2023). Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators. Seminars in Respiratory and Critical Care Medicine, 44 (02), 287-296. doi: 10.1055/s-0042-1759883

Ruseckaite, Rasa, Salimi, Farhad, Earnest, Arul, Bell, Scott C., Douglas, Tonia, Frayman, Katherine, Keatley, Lucy, King, Susannah, Kotsimbos, Tom, Middleton, Peter G., Morey, Sue, Mulrennan, Siobhain, Schultz, Andre, Wainwright, Claire, Ward, Nathan, Wark, Peter and Ahern, Susannah (2022). Survival of people with cystic fibrosis in Australia. Scientific Reports, 12 (1) 19748, 1-9. doi: 10.1038/s41598-022-24374-4

Begum, Nelufa, Byrnes, Catherine A., Cheney, Joyce, Cooper, Peter J., Fantino, Emmanuelle, Gailer, Nicholas, Grimwood, Keith, GutierrezCardenas, Diana, Massie, John, Robertson, Colin F., Sly, Peter D., Tiddens, Harm A.W.M., Wainwright, Claire E. and Ware, Robert S. (2022). Factors in childhood associated with lung function decline to adolescence in cystic fibrosis. Journal of Cystic Fibrosis, 21 (6), 977-983. doi: 10.1016/j.jcf.2022.03.008

Wainwright, Claire E (2022). A New Era for Cystic Fibrosis and CFTR Modulator Trials in Infants. American Journal of Respiratory and Critical Care Medicine, 206 (10), 1193-1195. doi: 10.1164/rccm.202207-1356ed

Mall, Marcus A., Brugha, Rossa, Gartner, Silvia, Legg, Julian, Moeller, Alexander, Mondejar-Lopez, Pedro, Prais, Dario, Pressler, Tacjana, Ratjen, Felix, Reix, Philippe, Robinson, Paul D., Selvadurai, Hiran, Stehling, Florian, Ahluwalia, Neil, Arteaga-Solis, Emilio, Bruinsma, Bote G., Jennings, Mark, Moskowitz, Samuel M., Noel, Sabrina, Tian, Simon, Weinstock, Tanya G., Wu, Pan, Wainwright, Claire E., Davies, Jane C. and for the VX19-445-116 Study Group (2022). Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3B, Randomized, Placebo-Controlled Study. American Journal of Respiratory and Critical Care Medicine, 206 (11), 1361-1369. doi: 10.1164/rccm.202202-0392oc

Sawicki, Gregory S., Chilvers, Mark, McNamara, John, Naehrlich, Lutz, Saunders, Clare, Sermet-Gaudelus, Isabelle, Wainwright, Claire E., Ahluwalia, Neil, Campbell, Daniel, Harris, R. Scott, Paz-Diaz, Hildegarde, Shih, Judy L. and Davies, Jane C. (2022). A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children ≥ 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variant. Journal of Cystic Fibrosis, 21 (4), 675-683. doi: 10.1016/j.jcf.2022.02.003

Tiddens, Harm A. W. M., Chen, Yuxin, Andrinopoulou, Eleni-Rosalina, Davis, Stephanie D, Rosenfeld, Margaret, Ratjen, Felix, Kronmal, Richard A., Hinckley Stukovsky, Karen D., Dasiewicz, Alison, Stick, Stephen Michael, Andrinopoulou, Eleni-Rosalina, Anthony, Margaret M., Au, Jacky, Belessis, Yvonne, Bonte, Merlijn, Chen, Yuxin, Cheney, Joyce, Clem, Charles, Clements, Barry, Cooper, Peter, Dasiewicz, Alison, Davis, Stephanie D., Davis, Miriam, de Boeck, Kris, de Marchis, Matteo, De Wachter, Elke, Delaisi, Bertrand, Delaup, Véronique, DeRicco, Adrienne ... on behalf of the SHIP-CT Study Group (2022). The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial. The Lancet Respiratory Medicine, 10 (7), 669-678. doi: 10.1016/s2213-2600(21)00546-4

Stick, Stephen M, Foti, Alexia, Ware, Robert S, Tiddens, Harm A W M, Clements, Barry S, Armstrong, David S, Selvadurai, Hiran, Tai, Andrew, Cooper, Peter J, Byrnes, Catherine A, Belessis, Yvonne, Wainwright, Claire, Jaffe, Adam, Robinson, Philip, Saiman, Lisa and Sly, Peter D (2022). The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial. The Lancet Respiratory Medicine, 10 (8), 776-784. doi: 10.1016/s2213-2600(22)00165-5

Sutharsan, Sivagurunathan, McKone, Edward F., Downey, Damian G., Duckers, Jamie, MacGregor, Gordon, Tullis, Elizabeth, Van Braeckel, Eva, Wainwright, Claire E., Watson, Danie, Ahluwalia, Neil, Bruinsma, Bote G., Harris, Christopher, Lam, Anna P., Lou, Yiyue, Moskowitz, Samuel M., Tian, Simon, Yuan, Jason, Waltz, David, Mall, Marcus A., Aurora, Paul, Verhulst, Stijn, Lorenz, Michael, Roehmel, Jobst, Gleiber, Wolfgang, Naehrig, Susanne, Stehling, Florian, van Koningsbruggen-Rietschel, Silke, Fischer, Rainald, Downey, Damian ... Wark, Peter (2022). Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial. The Lancet Respiratory Medicine, 10 (3), 267-277. doi: 10.1016/S2213-2600(21)00454-9

Kelk, Dean, Logan, Jayden, Andersen, Isabella, Gutierrez Cardenas, Diana, Bell, Scott C., Wainwright, Claire E., Sly, Peter D. and Fantino, Emmanuelle (2022). Neutrophil respiratory burst activity is not exaggerated in cystic fibrosis. Journal of Cystic Fibrosis, 21 (4), 707-712. doi: 10.1016/j.jcf.2021.12.015

Kleidon, Tricia M., Schults, Jessica A., Wainwright, Claire, Mihala, Gabor, Gibson, Victoria, Saiyed, Masnoon, Byrnes, Joshua, Cattanach, Paula, Macfarlane, Fiona, Graham, Nicolette, Shevill, Elizabeth and Ullman, Amanda J. (2021). Comparison of midline catheters and peripherally inserted central catheters to reduce the need for general anesthesia in children with respiratory disease: A feasibility randomized controlled trial. Pediatric Anesthesia, 31 (9) pan.14229, 985-995. doi: 10.1111/pan.14229

Zemanick, Edith T., Taylor-Cousar, Jennifer L., Davies, Jane, Gibson, Ronald L., Mall, Marcus A., McKone, Edward F., McNally, Paul, Ramsey, Bonnie W., Rayment, Jonathan H., Rowe, Steven M., Tullis, Elizabeth, Ahluwalia, Neil, Chu, Chenghao, Ho, Thang, Moskowitz, Samuel M., Noel, Sabrina, Tian, Simon, Waltz, David, Weinstock, Tanya G., Xuan, Fengjuan, Wainwright, Claire E. and McColley, Susanna A. (2021). A phase 3 open-label study of elexacaftor/tezacaftor/ivacaftor in children 6 through 11 years of age with cystic fibrosis and at least one F508del allele. American Journal of Respiratory and Critical Care Medicine, 203 (12), 1522-1532. doi: 10.1164/rccm.202102-0509OC

Wong, Matthew D., Patel, Chirag, McTaggart, Steven and Wainwright, Claire E. (2021). Atypical haemolytic uraemic syndrome in a child with cystic fibrosis. Journal of Paediatrics and Child Health, 58 (3) jpc.15571, 532-535. doi: 10.1111/jpc.15571

Strachan, Roxanne, Homaira, Nusrat, Beggs, Sean, Bhuiyan, Mejbah U., Gilbert, Gwendolyn L., Lambert, Stephen B., Macartney, Kristine, Marshall, Helen, Martin, Andrew C., McCallum, Gabrielle B., McCullagh, Angela, McDonald, Tim, McIntyre, Peter, Oftadeh, Shahin, Ranganathan, Sarath, Suresh, Sadasivam, Wainwright, Claire E., Wilson, Angela, Wong, Melanie, Snelling, Thomas and Jaffé, Adam (2021). Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia. Thorax, 76 (5), 487-493. doi: 10.1136/thoraxjnl-2020-216032

Bayfield, Katie J., Douglas, Tonia A., Rosenow, Tim, Davies, Jane Carolyn, Elborn, Stuart J., Mall, Marcus, Paproki, Anthony, Ratjen, Felix, Sly, Peter D., Smyth, Alan R., Stick, Stephen, Wainwright, Claire E. and Robinson, Paul D. (2021). Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis. Thorax, 76 (12), 1-11. doi: 10.1136/thoraxjnl-2020-216085

Bordin, Amanda, Pandey, Sushil, Coulter, Christopher, Syrmis, Melanie, Pardo, Carolyn, Hackett, Hazel, Bell, Scott C., Wainwright, Claire E., Nimmo, Graeme R., Jennison, Amy V., Clark, Julia E. and Whiley, David M. (2021). Rapid macrolide and amikacin resistance testing for Mycobacterium abscessus in people with cystic fibrosis. Journal of Medical Microbiology, 70 (4) 001349, 1-11. doi: 10.1099/jmm.0.001349

Ahern, Susannah, Dean, Joanne, Liman, John, Ruseckaite, Rasa, Burke, Nettie, Gollan, Morgan, Keatley, Lucy, King, Susannah, Kotsimbos, Tom, Middleton, Peter G., Schultz, Andre, Wainwright, Claire, Wark, Peter and Bell, Scott (2021). Redesign of the Australian Cystic Fibrosis Data Registry: a multidisciplinary collaboration. Paediatric Respiratory Reviews, 37, 37-43. doi: 10.1016/j.prrv.2020.03.001

Davies, Jane C., Wainwright, Claire E., Sawicki, Gregory S., Higgins, Mark N., Campbell, Daniel, Harris, Christopher, Panorchan, Paul, Haseltine, Eric, Tian, Simon and Rosenfeld, Margaret (2021). Ivacaftor in infants aged 4 to <12 months with cystic fibrosis and a gating mutation results of a two-part phase 3 clinical trial. American Journal of Respiratory and Critical Care Medicine, 203 (5), 585-593. doi: 10.1164/rccm.202008-3177OC

Sherrard, Laura J., Wee, Bryan A., Duplancic, Christine, Ramsay, Kay A., Dave, Keyur A., Ballard, Emma, Wainwright, Claire E., Grimwood, Keith, Sidjabat, Hanna E., Whiley, David M., Beatson, Scott A., Kidd, Timothy J. and Bell, Scott C. (2021). Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosis. Journal of Cystic Fibrosis, 21 (1), e35-e43. doi: 10.1016/j.jcf.2021.03.007

Davies, Jane C., Sermet-Gaudelus, Isabelle, Naehrlich, Lutz, Harris, R. Scott, Campbell, Daniel, Ahluwalia, Neil, Short, Christopher, Haseltine, Eric, Panorchan, Paul, Saunders, Clare, Owen, Caroline A. and Wainwright, Claire E. (2021). A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation. Journal of Cystic Fibrosis, 20 (1), 68-77. doi: 10.1016/j.jcf.2020.07.023

Flume, Patrick A., Biner, Reta Fischer, Downey, Damian G., Brown, Cynthia, Jain, Manu, Fischer, Rainald, De Boeck, Kris, Sawicki, Gregory S., Chang, Philip, Paz-Diaz, Hildegarde, Rubin, Jaime L., Yang, Yoojung, Hu, Xingdi, Pasta, David J., Millar, Stefanie J., Campbell, Daniel, Wang, Xin, Ahluwalia, Neil, Owen, Caroline A., Wainwright, Claire E., Gibson, Ronald L., Rowe, Steven M., Lechtzin, Noah, Ahrens, Richard C., McCoy, Karen S., Aitken, Moira, Donaldson, Scott H., McBennett, Kimberly Ann, Pilewski, Joseph M. ... on behalf of the VX14-661-110 study group (2021). Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study. The Lancet Respiratory Medicine, 9 (7), 733-746. doi: 10.1016/S2213-2600(20)30510-5

Taylor, Steven L., Leong, Lex E.X., Ivey, Kerry L., Wesselingh, Steve, Grimwood, Keith, Wainwright, Claire E. and Rogers, Geraint B. (2020). Total bacterial load, inflammation, and structural lung disease in paediatric cystic fibrosis. Journal of Cystic Fibrosis, 19 (6), 923-930. doi: 10.1016/j.jcf.2020.03.008

Munck, Anne, Kerem, Eitan, Ellemunter, Helmut, Campbell, Daniel, Wang, Linda T., Ahluwalia, Neil, Owen, Caroline A. and Wainwright, Claire (2020). Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutations. Journal of Cystic Fibrosis, 19 (6), 962-968. doi: 10.1016/j.jcf.2020.04.015

Earnest, Arul, Salimi, Farhad, Wainwright, Claire E., Bell, Scott C., Ruseckaite, Rasa, Ranger, Tom, Kotsimbos, Tom and Ahern, Susannah (2020). Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry. Scientific Reports, 10 (1) 17421, 17421. doi: 10.1038/s41598-020-74502-1

Yeo, Abrey J., Henningham, Anna, Fantino, Emmanuelle, Galbraith, Sally, Krause, Lutz, Wainwright, Claire E., Sly, Peter D. and Lavin, Martin F. (2020). Author Correction: Increased susceptibility of airway epithelial cells from ataxia-telangiectasia to S. pneumoniae infection due to oxidative damage and impaired innate immunity. Scientific Reports, 10 (1) 12742, 12742. doi: 10.1038/s41598-020-69649-w

Wijker, Naomi E., Vidmar, Suzanna, Grimwood, Keith, Sly, Peter D., Byrnes, Catherine A., Carlin, John B., Cooper, Peter J., Robertson, Colin F., Massie, R. John, Kemner van de Corput, Mariette P. C., Cheney, Joyce, Tiddens, Harm A.W.M. and Wainwright, Claire E. (2020). Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort. European Respiratory Journal, 55 (4) 1901694, 1901694. doi: 10.1183/13993003.01694-2019

Geake, James, Ballard, Emma, O'Rourke, Peter, Wainwright, Claire E., Reid, David W. and Bell, Scott C. (2020). Centralised versus outreach models of cystic fibrosis care should be tailored to the needs of the individual patient. Internal Medicine Journal, 50 (2), 232-235. doi: 10.1111/imj.14724

Stockwell, Rebecca Elizabeth, Wood, Michelle ELizabeth, Ballard, Emma, Moore, Vanessa, Wainwright, Claire Elizabeth and Bell, Scott Cameron (2020). Current infection control practices used in Australian and New Zealand cystic fibrosis centers. BMC Pulmonary Medicine, 20 (1) 16, 16. doi: 10.1186/s12890-020-1052-y

Wainwright, Claire E. (2020). New therapies for people with CF in the CFTR modulator world. Journal of Cystic Fibrosis, 19 (5), 669-670. doi: 10.1016/j.jcf.2020.07.019

Chacko, Archana, Wen, Sophie CH, Hartel, Gunter, Kapur, Nitin, Wainwright, Claire E. and Clark, Julia E. (2019). Improved clinical outcome following treatment of Mycobacterium abscessus complex pulmonary disease in children with cystic fibrosis. Pediatric Infectious Disease Journal, 38 (7), 660-666. doi: 10.1097/inf.0000000000002274

Harun, Sabariah Noor, Holford, Nicholas H. G., Grimwood, Keith, Wainwright, Claire E. and Hennig, Stefanie (2019). Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis. Thorax, 74 (8), thoraxjnl-2018. doi: 10.1136/thoraxjnl-2018-211548

Yeo, Abrey J., Henningham, Anna, Fantino, Emmanuelle, Galbraith, Sally, Krause, Lutz, Wainwright, Claire E., Sly, Peter D. and Lavin, Martin F. (2019). Increased susceptibility of airway epithelial cells from ataxia-telangiectasia to S. pneumoniae infection due to oxidative damage and impaired innate immunity. Scientific Reports, 9 (1) 2627, 2627. doi: 10.1038/s41598-019-38901-3

McColley, Susanna A., Konstan, Michael W., Ramsey, Bonnie W., Stuart Elborn, J., Boyle, Michael P., Wainwright, Claire E., Waltz, David, Vera-Llonch, Montserrat, Marigowda, Gautham, Jiang, John G. and Rubin, Jaime L. (2019). Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1. Journal of Cystic Fibrosis, 18 (1), 94-101. doi: 10.1016/j.jcf.2018.07.011

Tong, Koliarne, Barker, Daniel, France, Megan, Burr, Lucy, Greville, Hugh, Visser, Simone, Middleton, Peter, Wainwright, Claire, Dorahy, Douglas and Wark, Peter (2019). Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease. Journal of Cystic Fibrosis, 19 (3), 415-420. doi: 10.1016/j.jcf.2019.12.006

Martin, Lois W., Robson, Cynthia L., Watts, Annabelle M., Gray, Andrew R., Wainwright, Claire E., Bell, Scott C., Ramsay, Kay A., Kidd, Timothy J., Reid, David W., Brockway, Ben and Lamont, Iain L. (2018). Expression of Pseudomonas aeruginosa antibiotic resistance genes varies greatly during infections in cystic fibrosis patients. Antimicrobial Agents and Chemotherapy, 62 (11) e01789-18. doi: 10.1128/AAC.01789-18

Harun, Sabariah Noor, Wainwright, Claire E., Grimwood, Keith, Hennig, Stefanie and Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) study group (2018). Aspergillus and progression of lung disease in children with cystic fibrosis. Thorax, 74 (2), thoraxjnl-2018. doi: 10.1136/thoraxjnl-2018-211550

Jain, Kamini, Wainwright, Claire and Smyth, Alan R (2018). Bronchoscopy-guided antimicrobial therapy for cystic fibrosis. Cochrane Database of Systematic Reviews, 2018 (9) CD009530. doi: 10.1002/14651858.CD009530.pub4

Ruseckaite, Rasa, Pekin, Natalie, King, Susannah, Carr, Erin, Ahern, Susannah, Oldroyd, John, Earnest, Arul, Wainwright, Claire and Armstrong, David (2018). Evaluating the impact of 2006 Australasian Clinical Practice Guidelines for nutrition in children with cystic fibrosis in Australia. Respiratory Medicine, 142, 7-14. doi: 10.1016/j.rmed.2018.07.007

Rosenfeld, Margaret, Wainwright, Claire E., Higgins, Mark, Wang, Linda T., McKee, Charlotte, Campbell, Daniel, Tian, Simon, Schneider, Jennifer, Cunningham, Steve, Davies, Jane C. and ARRIVAL study group (2018). Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study. The Lancet Respiratory Medicine, 6 (7), 545-553. doi: 10.1016/S2213-2600(18)30202-9

Stouffer, Daniel B., Wainwright, Claire E., Flanagan, Thomas and Mayfield, Margaret M. (2018). Cyclic population dynamics and density-dependent intransitivity as pathways to coexistence between co-occurring annual plants. Journal of Ecology, 106 (3), 838-851. doi: 10.1111/1365-2745.12960

Wood, Michelle E., Stockwell, Rebecca E., Johnson, Graham R., Ramsay, Kay A., Sherrard, Laura J., Kidd, Timothy J., Cheney, Joyce, Ballard, Emma L., O'Rourke, Peter, Jabbour, Nassib, Wainwright, Claire E., Knibbs, Luke D., Sly, Peter D., Morawska, Lidia and Bell, Scott C. (2018). Cystic fibrosis pathogens survive for extended periods within cough-generated droplet nuclei. Thorax, 74 (1), thoraxjnl-2018. doi: 10.1136/thoraxjnl-2018-211567

Wood, Michelle E., Stockwell, Rebecca E., Johnson, Graham R., Ramsay, Kay A., Sherrard, Laura J., Jabbour, Nassib, Ballard, Emma, O'Rourke, Peter, Kidd, Timothy J., Wainwright, Claire E., Knibbs, Luke D., Sly, Peter D., Morawska, Lidia and Bell, Scott C. (2018). Face masks and cough etiquette reduce the cough aerosol concentration of Pseudomonas aeruginosa in people with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 197 (3), 338-355. doi: 10.1164/rccm.201707-1457OC

Tarique, Abdullah A., Sly, Peter D., Cardenas, Diana G., Luo, Lin, Stow, Jennifer L., Bell, Scott C., Wainwright, Claire E. and Fantino, Emmanuelle (2018). Differential expression of genes and receptors in monocytes from patients with cystic fibrosis. Journal of Cystic Fibrosis, 18 (3), 342-348. doi: 10.1016/j.jcf.2018.07.012

Yeo, Abrey J., Fantino, Emmanuelle, Czovek, Dorottya, Wainwright, Claire E., Sly, Peter D. and Lavin, Martin F. (2017). Loss of ATM in airway epithelial cells is associated with susceptibility to oxidative stress. American Journal of Respiratory and Critical Care Medicine, 196 (3), 391-393. doi: 10.1164/rccm.201611-2210LE

Sly, Peter D. and Wainwright, Claire E. (2017). Preserving lung function: the holy grail in managing cystic fibrosis. Annals of the American Thoracic Society, 14 (6), 833-835. doi: 10.1513/AnnalsATS.201703-254ED

Fajac, Isabelle and Wainwright, Claire E. (2017). New treatments targeting the basic defects in cystic fibrosis. Presse Medicale, 46 (6), E165-E175. doi: 10.1016/j.lpm.2017.01.024

Pereira, M. L., Knibbs, L. D., He, C., Grzybowski, P., Johnson, G. R., Huffman, J. A., Bell, S. C., Wainwright, C. E., Matte, D. L., Dominski, F. H., Andrade, A. and Morawska, L. (2017). Sources and dynamics of fluorescent particles in hospitals. Indoor Air, 27 (5), 988-1000. doi: 10.1111/ina.12380

Gibson, Peter G., Peters, Matthew J. and Wainwright, Claire E. (2017). Targeted therapy for chronic respiratory disease: a new paradigm. Medical Journal of Australia, 206 (3), 136-140. doi: 10.5694/mja16.00731

Sly, Peter D. and Wainwright, Claire E. (2016). Diagnosis and early life risk factors for bronchiectasis in cystic fibrosis: a review. Expert Review of Respiratory Medicine, 10 (9), 1003-1010. doi: 10.1080/17476348.2016.1204915

Elborn, J. Stuart, Ramsey, Bonnie W., Boyle, Michael P., Konstan, Michael W., Huang, Xiaohong, Marigowda, Gautham, Waltz, David and Wainwright, Claire E. (2016). Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup: a pooled analysis. Lancet Respiratory Medicine, 4 (8), 617-626. doi: 10.1016/S2213-2600(16)30121-7

Noor Harun, Sabariah, Wainwright, Claire, Klein, Kerenaftali and Hennig, Stefanie (2016). A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis.. Paediatric Respiratory Reviews, 20, 55-66. doi: 10.1016/j.prrv.2016.03.002

Smith, Daniel J., Ramsay, Kay A., Yerkovich, Stephanie T., Reid, David W., Wainwright, Claire E., Grimwood, Keith, Bell, Scott C. and Kidd, Timothy J. (2016). Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres. Respirology, 21 (2), 329-337. doi: 10.1111/resp.12714

Elborn, J. Stuart, Ramsey, Bonnie, Wainwright, Claire and Boyle, Michael (2016). Response to: 'Lumacaftor/ivacaftor for patients homozygous for Phe508del-CFTR: should we curb our enthusiasm?' by Jones and Barry. Thorax, 71 (2), 185-186. doi: 10.1136/thoraxjnl-2015-207611

Jain, Kamini, Wainwright, Claire and Smyth, Alan R. (2016). Bronchoscopy-guided antimicrobial therapy for cystic fibrosis. Cochrane Database of Systematic Reviews, 2016 (1) CD009530. doi: 10.1002/14651858.CD009530.pub3

Tai, Anna Sze, Bell, Scott Cameron, Kidd, Timothy James, Trembizki, Ella, Buckley, Cameron, Ramsay, Kay Annette, David, Michael, Wainwright, Claire Elizabeth, Grimwood, Keith and Whiley, David Mark (2015). Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis. Plos One, 10 (12) e0144022, e0144022. doi: 10.1371/journal.pone.0144022

Wainwright, Claire E., Elborn, J. Stuart and Ramsey, Bonnie W. (2015). The authors reply. New England Journal of Medicine, 373 (18), 1783-1784. doi: 10.1056/NEJMc1510466

Zhang, Linjie, Mendoza-Sassi, Raul A., Klassen, Terry P. and Wainwright, Claire (2015). Nebulized hypertonic saline for acute bronchiolitis: a systematic review. Pediatrics, 136 (4), 687-701. doi: 10.1542/peds.2015-1914

Ormerod, Kate L., George, Narelle M., Fraser, James A., Wainwright, Claire and Hugenholtz, Philip (2015). Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients. PeerJ, 3 (9) e1223, e1223.1-e1223.27. doi: 10.7717/peerj.1223

Wainwright, Claire E. and Kapur, Nitin (2015). Oxygen saturation targets in infants with bronchiolitis. The Lancet, 386 (9998) 398, 1016-1018. doi: 10.1016/S0140-6736(15)00155-5

Stacey, Sonya R., Coombes, Ian, Cardiff, Lynda, Wainwright, Claire and Whitfield, Karen M. (2015). Using the general levelframework to guide training and development needs of pharmacists working in paediatrics. Journal of Pharmacy Practice and Research, 45 (3), 322-330. doi: 10.1002/jppr.1140

Wainwright, C. E., Elborn, J. S., Ramsey, B. W., Marigowda, G., Huang, X., Cipolli, M., Colombo, C., Davies, J. C., De Boeck, K., Flume, P. A., Konstan, M. W., McColley, S. A., McCoy, K., McKone, E. F., Munck, A., Ratjen, F., Rowe, S. M., Waltz, D., Boyle, M. P. and Traffic and Transport Study Group (2015). Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for phe508del CFTR. New England Journal of Medicine, 373 (3), 220-231. doi: 10.1056/NEJMoa1409547

Kidd, Timothy J., Ramsay, Kay A., Vidmar, Suzanna, Carlin, John B., Bell, Scott C., Wainwright, Claire E. and Grimwood, Keith (2015). Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years. Journal of Cystic Fibrosis, 14 (3), 361-369. doi: 10.1016/j.jcf.2014.12.007

Wainwright, Claire E. and Tullis, Elizabeth (2014). Electronic care records - can they fulfil their promise?. Journal of Cystic Fibrosis, 13 (6), 608-609. doi: 10.1016/j.jcf.2014.04.009

McKone, Edward F., Borowitz, Drucy, Drevinek, Pavel, Griese, Matthias, Konstan, Michael W., Wainwright, Claire, Ratjen, Felix, Sermet-Gaudelus, Isabelle, Plant, Barry, Munck, Anne, Jiang, Ying, Gilmartin, Geoffrey and Davies, Jane C. (2014). Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST). Lancet Respiratory Medicine, 2 (11), 902-910. doi: 10.1016/52213-2600(14)70218-8

Roder, D. M., Fong, K. M., Brown, M. P., Zalcberg, J. and Wainwright, C. E. (2014). Realising opportunities for evidence-based cancer service delivery and research: linking cancer registry and administrative data in Australia. European Journal of Cancer Care, 23 (6), 721-727. doi: 10.1111/ecc.12242

Wainwright, Claire E. (2014). Ivacaftor for patients with cystic fibrosis. Expert Review of Respiratory Medicine, 8 (5), 533-538. doi: 10.1586/17476348.2014.951333

Moodie, Marj, Lal, Anita, Vidmar, Suzanna, Armstrong, David S., Byrnes, Catherine A., Carlin, John B., Cheney, Joyce, Cooper, Peter J., Grimwood, Keith, Robertson, Colin F., Tiddens, Harm A. and Wainwright, Claire E. (2014). Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis. Journal of Pediatrics, 165 (3), 564-569.e5. doi: 10.1016/j.jpeds.2014.05.031

Knibbs, Luke D., Johnson, Graham R., Kidd, Timothy J., Cheney, Joyce, Grimwood, Keith, Kattenbelt, Jacqueline A., O'Rourke, Peter K., Ramsay, Kay A., Sly, Peter D., Wainwright, Claire E., Wood, Michelle E., Morawska, Lidia and Bell, Scott C. (2014). Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis. Thorax, 69 (8), 740-745. doi: 10.1136/thoraxjnl-2014-205213

Stacey, Sonya, Coombes, Ian, Wainwright, Claire, Klee, Brittany, Miller, Hugh and Whitfield, Karen (2014). Characteristics of adverse medication events in a children's hospital. Journal of Paediatrics and Child Health, 50 (12), 966-971. doi: 10.1111/jpc.12684

Syrmis, Melanie W., Kidd, Timothy J., Moser, Ralf J., Ramsay, Kay A., Gibson, Kristen M., Anuj, Snehal, Bell, Scott C., Wainwright, Claire E., Grimwood, Keith, Nissen, Michael, Sloots, Theo P. and Whiley, David M. (2014). A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosis. BMC Infectious Diseases, 14 (1) 307, 307.1-307.8. doi: 10.1186/1471-2334-14-307

Stacey, Sonya R., Coombes, Ian, Wainwright, Claire, Cardiff, Lynda and Whitfield, Karen (2014). What does advanced practice mean to Australian paediatric pharmacists? A focus group study. International Journal of Pharmacy Practice, 23 (2), 141-149. doi: 10.1111/ijpp.12113

Leung, Chi Chiu, Porcel, Jose M., Takahashi, Kazuhisa, Restrepo, Marcos I., Lee, Pyng and Wainwright, Claire (2014). Year in review 2013: lung cancer, respiratory infections, tuberculosis, cystic fibrosis, pleural diseases, bronchoscopic intervention and imaging. Respirology, 19 (3), 448-460. doi: 10.1111/resp.12250

Hennig, Stefanie, McKay, Karen, Vidmar, Suzanna, O'Brien, Katie, Stacey, Sonya, Cheney, Joyce and Wainwright, Claire E. (2014). Safety of inhaled (TOBI(R)) and intravenous tobramycin in young children with cystic fibrosis. Journal of Cystic Fibrosis, 13 (4), 428-434. doi: 10.1016/j.jcf.2014.01.014

Jain, Kamini, Wainwright, Claire and Smyth, Alan R. (2013). Bronchoscopy-guided antimicrobial therapy for cystic fibrosis. Cochrane Database of Systematic Reviews, 2013 (12) CD009530. doi: 10.1002/14651858.CD009530.pub2

Ramsay, Kay A., Butler, Claire A., Paynter, Stuart, Ware, Robert S., Kidd, Timothy J., Wainwright, Claire E. and Bell, Scott C. (2013). Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis. Journal of Clinical Microbiology, 51 (12), 3975-3980. doi: 10.1128/JCM.01360-13

Zhang, Linjie, Mendoza-Sassi, Raul A., Wainwright, Claire and Klassen, Terry P. (2013). Nebulised hypertonic saline solution for acute bronchiolitis in infants (Review). Cochrane Database of Systematic Reviews, 136 (7), 687-701. doi: 10.1002/14651858.CD006458.pub3

Byrnes, Catherine Ann, Vidmar, Suzanna, Cheney, Joyce L., Carlin, John B., Armstrong, David S., Cooper, Peter J., Grimwood, Keith, Moodie, Marj, Robertson, Colin F., Rosenfeld, Margaret, Tiddens, Harm A. and Wainwright, Claire E. (2013). Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax, 68 (7), 643-651. doi: 10.1136/thoraxjnl-2012-202342

Davies, Jane C., Wainwright, Claire E., Canny, Gerard J., Chilvers, Mark A., Howenstine, Michelle S., Munck, Anne, Mainz, Jochen G., Rodriguez, Sally, Li, Haihong, Yen, Karl, Ordonez, Claudia L. and Ahrens, Richard (2013). Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation. American Journal of Respiratory and Critical Care Medicine, 187 (11), 1219-1225. doi: 10.1164/rccm.201301-0153OC

Syrmis, Melanie W., Moser, Ralf J., Kidd, Timothy J., Hunt, Priscilla, Ramsay, Kay A., Bell, Scott C., Wainwright, Claire E., Grimwood, Keith, Nissen, Michael D., Sloots, Theo P. and Whiley, David M. (2013). High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform. Journal of Medical Microbiology, 62 (5), 734-740. doi: 10.1099/jmm.0.055905-0

Hu, H., Harmer, C., Anuj, S., Wainwright, C. E., Manos, J., Cheney, J., Harbour, C., Zablotska, I., Turnbull, L., Whitchurch, C. B., Grimwood, K., Rose, B. and ACFBAL study investigators (2013). Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening. Clinical Microbiology and Infection, 19 (3), 266-272. doi: 10.1111/j.1469-0691.2012.03770.x

Manos J., Hu H., Rose B.R., Wainwright C.E., Zablotska I.B., Cheney J., Turnbull L., Whitchurch C.B., Grimwood K., Harmer C., Anuj S.N. and Harbour C. (2013). Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis. European Journal of Clinical Microbiology and Infectious Diseases, 32 (12), 1583-1592. doi: 10.1007/s10096-013-1916-7

Ratjen, Felix, Durham, Todd, Navratil, Tomas, Schaberg, Amy, Accurso, Frank J., Wainwright, Claire, Barnes, Matthew, Moss, Richard B. and the TIGER-2 Study Investigator Group (2012). Long term effects of denufosol tetrasodium in patients with cystic fibrosis. Journal of Cystic Fibrosis, 11 (6), 539-549. doi: 10.1016/j.jcf.2012.05.003

Kidd, Timothy J., Ramsay, Kay A., Hu, Honghua, Marks, Guy B., Wainwright, Claire E., Bye, Peter T., Elkins, Mark R., Robinson, Philip J., Rose, Barbara R., Wilson, John W., Grimwood, Keith, Bell, Scott C., ACPinCF Investigator Group, Serisier, David J. and Smith, Daniel J. (2012). Shared pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. European Respiratory Journal, 41 (5), 1091-1100. doi: 10.1183/09031936.00060512

Willner, Dana, Daly, Joshua, Whiley, David, Grimwood, Keith, Wainwright, Claire E. and Hugenholtz, Philip (2012). Comparison of DNA extraction methods for microbial community profiling with an application to pediatric bronchoalveolar lavage samples. PLoS One, 7 (4) e34605, e34605.1-e34605.12. doi: 10.1371/journal.pone.0034605

Strachan, Roxanne E., Cornelius, Anita, Gilbert, Gwendolyn L., Gulliver, Tanya, Martin, Andrew, McDonald, Tim, Nixon, Gillian, Roseby, Rob, Ranganathan, Sarath, Selvadurai, Hiran, Smith, Greg, Soto-Martinez, Manuel, Suresh, Sadasivam, Teoh, Laurel, Thapa, Kiran and Wainwright, Claire E. (2012). Pleural fluid nucleic acid testing enhances pneumococcal surveillance in children. Respirology, 17 (1), 114-119. doi: 10.1111/j.1440-1843.2011.02035.x

Collaco, Joseph M., McGready, John, Green, Deanna M., Naughton, Kathleen M., Watson, Christopher P., Shields, Timothy, Bell, Scott C., Wainwright, Claire E. and Cutting, Garry R. (2011). Effect of temperature on cystic fibrosis lung disease and infections: A replicated cohort study. PLoS One, 6 (11) e27784, 1-7. doi: 10.1371/journal.pone.0027784

Wainwright, Claire E. (2011). Treatment of cystic fibrosis following infant screening. Therapy, 8 (6), 613-622. doi: 10.2217/thy.11.80

Ramsey, Bonnie W., Davies, Jane, McElvaney, N. Gerard, Tullis, Elizabeth, Bell, Scott C., Drevinek, Pavel, Griese, Matthias, McKone, Edward F., Wainwright, Claire E., Konstan, Michael W., Moss, Richard, Ratjen, Felix, Sermet-Gaudelus, Isabelle, Rowe, Steven M., Dong, Qunming, Rodriguez, Sally, Yen, Karl, Ordonez, Claudia and Elborn, J. Stuart (2011). A CFTR potentiator in patients with Cystic Fibrosis and the G551D Mutation. New England Journal of Medicine, 365 (18), 1663-1672. doi: 10.1056/NEJMoa1105185

Wainwright, Claire E., Carlin, John B. and Grimwood, Keith (2011). Bronchoalveolar lavage-directed therapy in children with cystic fibrosis and Pseudomonas aeruginosa infection. Jama-Journal of the American Medical Association, 306 (16), 1761-1762. doi: 10.1001/jama.2011.1519

Strachan, Roxanne E., Cornelius, Anita, Gilbert, Gwendolyn L., Gulliver, Tanya, Martin, Andrew, McDonald, Tim, Nixon, Gillian M., Roseby, Rob, Ranganathan, Sarath, Selvadurai, Hiran, Smith, Greg, Soto-Martinez, Manuel, Suresh, Sadasivam, Teoh, Laurel, Thapa, Kiran, Wainwright, Claire E. and Jaffe, Adam (2011). Bacterial causes of empyema in children, Australia, 2007-2009. Emerging Infectious Diseases, 17 (10), 1839-1845. doi: 10.3201/eid1710.101825

Anuj, S. N., Whiley, D. M., Kidd, T. J., Ramsay, K. A., Bell, S. C., Syrmis, M. W., Grimwood, K., Wainwright, C. E., Nissen, M. D. and Sloots, T. P. (2011). Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time PCR and high-resolution melting curve analysis. Clinical Microbiology and Infection, 17 (9), 1403-1408. doi: 10.1111/j.1469-0691.2010.03439.x

Santos, Jose C. H., Zhang, Linjie, Menegatti, Paula K., Guasselli, Camila S., Filho, Celso C. M., Maito, Lina R. D. M., Ferreira, Marina F., Mariani, Monallisa C. and Wainwright, Claire (2011). Pneumonia in the first 2 years of life, and asthma in preschool-age children. Pediatrics International, 53 (4), 576-580. doi: 10.1111/j.1442-200X.2011.03333.x

Wainwright, Claire E., Vidmar, Suzanna, Armstrong, David S., Byrnes, Catherine A., Carlin, John B., Cheney, Joyce, Cooper, Peter J., Grimwood, Keith, Moodie, Marj, Robertson, Colin F. and Tiddens, Harm A. (2011). Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: A randomized trial. JAMA: Journal of the American Medical Association, 306 (2), 163-171. doi: 10.1001/jama.2011.954

Wainwright, C. E., Quittner, A. L., Geller, D. E., Nakamura, C., Wooldridge, J. L., Gibson, R. L., Lewis, S. and Montgomery, A. B. (2011). Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa. Journal of Cystic Fibrosis, 10 (4), 234-242. doi: 10.1016/j.jcf.2011.02.007

Reddel, Helen K., Lim, T. K., Mishima, Michiaki, Wainwright, Claire E. and Knight, Darryl A. (2011). Year-in-review 2010: Asthma, COPD, cystic fibrosis and airway biology. Respirology, 16 (3), 540-552. doi: 10.1111/j.1440-1843.2011.01949.x

Strachan, Roxanne E., Cornelius, Anita, Gilbert, Gwendolyn L., Gulliver, Tanya, Martin, Andrew, McDonald, Tim, Nixon, Gillian, Roseby, Rob, Ranganathan, Sarath, Selvadurai, Hiran, Smith, Greg, Soto-Martinez, Manuel, Suresh, Sadasivam, Teoh, Laurel, Thapa, Kiran, Wainwright, Claire E. and Jaffe, Adam (2011). A bedside assay to detect streptococcus pneumoniae in children with empyema. Pediatric Pulmonology, 46 (2), 179-183. doi: 10.1002/ppul.21349

Douglas, Tonia A., Brennan, Siobhain, Berry, Luke, Winfield, Kaye, Wainwright, Claire E., Grimwood, Keith, Stick, Stephen M. and Sly, Peter D. (2010). Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis. Thorax, 65 (11), 985-990. doi: 10.1136/thx.2009.132845

Xu, Cathy, Jackson, Mary, Scuffham, Paul A., Wootton, Richard, Simpson, Pamela, Whitty, Jennifer, Wolfe, Rory and Wainwright, Claire E. (2010). A randomized controlled trial of an interactive voice response telephone system and specialist nurse support for childhood asthma management. Journal of Asthma, 47 (7), 768-773. doi: 10.3109/02770903.2010.493966

Arshi, Mandana, Cardinal, John, Hill, Rebecca J., Davies, Peter S. W. and Wainwright, Claire (2010). Asthma and insulin resistance in children. Respirology, 15 (5), 779-784. doi: 10.1111/j.1440-1843.2010.01767.x

Wainwright, C. E., France, M. W., O'Rourke, P., Anuj, S., Kidd, T. J., Nissen, M. D., Sloots, T. P., Coulter, C., Ristovski, Z., Hargreaves, M., Rose, B. R., Harbour, C., Bell, SC and Fennelly, KP (2009). Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis.. Thorax, 64 (11), 926-931. doi: 10.1136/thx.2008.112466

Truby, Helen, Cowlishaw, Patricia, O'Neil, Catherine and Wainwright, Claire (2009). The long term efficacy of gastrostomy feeding in children with cystic fibrosis on anthropometric markers of nutritonal status and pulmonary function. The Open Respiratory Medicine Journal, 3 (x), 112-115. doi: 10.2174/1874306400903010112

Kidd, TJ, Marks, GB, Bye, PTP, Wainwright, CE, Robinson, PJ, Rose, BR, Harbour, C and Bell, SC (2009). Multi-centre research in Australia: Analysis of a recent National Health and Medical Research Council-funded project. RESPIROLOGY, 14 (7), 1051-1055. doi: 10.1111/j.1440-1843.2009.01595.x

Quittner, AL, Modi, AC, Wainwright, C, Otto, K, Kirihara, J and Montgomery, AB (2009). Determination of the minimal clinically important difference scores for the cystic fibrosis questionnaire - Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic pseudomonas aeruginosa airway infection. Chest, 135 (6), 1610-1618. doi: 10.1378/chest.08-1190

Kidd, Timothy J., Ramsay, Kay A., Hu, Honghua Hu, Bye, Peter T. P., Elkins, Mark R., Grimwood, Keith, Harbour, Colin, Marks, Guy B., Nissen, Michael D., Robinson, Phillip J., Rose, Barbara R., Sloots, Theo P., Wainwright, Claire E., Bell, Scott C. and ACPinCF Investigators (2009). Low rates of Pseudomonas aeruginosa misidentification in isolates from Cystic Fibrosis patients.. Journal of Clinical Microbiology, 47 (5), 1503-1509. doi: 10.1128/JCM.00014-09

Hansen, Tarrant, Van Kerckhof, Janelle, Jelfs, Peter, Wainwright, Claire, Ryan, Pat and Coulter, Chris (2009). Segniliparus rugosus Infection, Australia. Emerging infectious diseases, 15 (4), 611-613. doi: 10.3201/eid1504.081479

Anuj, Snehal N., Whiley, David M., Kidd, Timothy J., Bell, Scott C., Wainwright, Claire E., Nissen, Michael D. and Sloots, Theo P. (2009). Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes. Diagnostic Microbiology And Infectious Disease, 63 (2), 127-131. doi: 10.1016/j.diagmicrobio.2008.09.018

Strachan, Roxanne, Jaffe, Adam, Bauert, Paul, Maclennan, Carolyn, Cornelius, Anita, Gilbert, Lyn, Gulliver, Tanya, Martin, Andrew, McDonald, Tim, Teoh, Laurel, Nixon, Gillian, Ranganathan, Sarath, Roseby, Rob, Selvadurai, Hiran, Smith, Greg, Suresh, Sadasivam and Wainwright, Claire (2009). Assessment of the burden of paediatric empyema in Australia. Journal of Paediatrics and Child Health, 45 (7-8), 431-436. doi: 10.1111/j.1440-1754.2009.01533.x

Zhang, Linjie, Mendoza-Sassi, Raul A., Wainwright, Claire and Klassen, Terry P. (2009). Nebulized hypertonic saline solution for acute bronchiolitis in infants: [Intervention Review]. Cochrane Database of Systematic Reviews, 136 (4) CD006458, 1-23. doi: 10.1002/14651858.CD006458.pub2

Wainwright, Claire (2009). Acute viral bronchiolitis in children - a very common condition with few therapeutic options. Paediatric Respiratory Reviews, 11 (1), 39-45. doi: 10.1016/j.prrv.2009.10.001

Wainwright, C. E., Grimwood, K., Carlin, J. B., Vidmar, S., Cooper, P.J., Francis, P. W. J., Byrnes, C.A., Whitehead, B.F., Martin, A. J., Robertson, I. F, Cooper, D. M., Dakin, C. J., Masters, I. B., Massie, R.J., Robinson, P. J., Ranganathan, S., Armstrong, D.S., Patterson, L. K. and Robertson, C. F. (2008). Safety of bronchoalveolar lavage in young children with cystic fibrosis. Pediatric Pulmonology, 43 (10), 965-972. doi: 10.1002/ppul.20885

Brennan, Siobhain, Gangell, Catherine, Wainwright, Claire and Sly, Peter D. (2008). Disease surveillance using bronchoalveolar lavage. Paediatric Respiratory Reviews, 9 (3), 151-159. doi: 10.1016/j.prrv.2008.01.002

Syrmis, Melanie, Bell, Scott, Bye, Peter, Coulter, Chris, Harbour, Colin, Iredell, Jon, Kidd, Tim, O'Carroll, Mark, Rose, Barbara, Wainwright, Claire, Sloots, Theo and Nissen, Michael (2008). High prevalence of a class 1 integron-associated aadB gene cassette in Pseudomonas aeruginosa isolates from an Australian cystic fibrosis patient population. Pathology, 40 (5), 524-525. doi: 10.1080/00313020802197921

Thomas, Clare L., O'Rourke, Peter K. and Wainwright, Claire E. (2008). Clinical outcomes of Queensland children with cystic fibrosis: a comparison between tertiary centre and outreach services. Medical Journal of Australia, 188 (3), 135-139.

Fitzgerald, Dominic, Massie, R. John H., Nixon, Gillian M., Jaffe, Adam, Wilson, Andrew, Landau, Louis I., Twiss, Jacob, Smith, Greg, Wainwright, Claire and Harris, Margaret (2008). Infants with chronic neonatal lung disease: recommendations for the use of home oxygen therapy. Medical Journal of Australia, 189 (10), 578-582. doi: 10.5694/j.1326-5377.2008.tb02186.x

McMorran, Brendan J., Patat, Severine A. Ouvry, Carlin, John B., Grimwood, Keith, Jones, Alun, Armstrong, David S., Galati, John C., Cooper, Peter J., Byrnes, Catherine A., Francis, Paul W., Robertson, Colin F., Hume, David A., Borchers, Christoph H., Wainwright, Claire E. and Wainwright, Brandon J. (2007). Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients. Clinical Chemistry, 53 (10), 1782-1791. doi: 10.1373/clinchem.2007.087650

McCormack, J. G., Bell, S. C., Senini, S., Walmsley, K., Patel, K., Wainwright, C., Serisier, D., Harris, M. and Bowler, S. (2007). Daily versus weekly azithromycin in cystic fibrosis patients.. European Respiratory Journal, 30 (3), 487-495. doi: 10.1183/09031936.00163306

Tingpej, Pholawat, Smith, Lucas, Rose, Barbara, Zhu, Hua, Conibear, Tim, Al Nassafi, Khaled, Manos, Jim, Elkins, Mark, Bye, Peter, Willcox, Mark, Bell, Scott, Wainwright, Claire and Harbour, Colin (2007). Phenotypic characterization of clonal and nonclonal Psuedomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. Journal of Clinical Microbiology, 45 (6), 1697-1704. doi: 10.1128/JCM.02364-06

Hennig, Stefanie, Waterhouse, Timothy H., Bell, Scott C., France, Megan, Wainwright, Claire E., Miller, Hugh, Charles, Bruce G. and Duffull, Stephen B. (2007). A D-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients. British Journal of Clinical Pharmacology, 63 (4), 438-450. doi: 10.1111/j.1365-2125.2006.02778.x

Cree, Michele, Stacey, Sonya, Graham, Nicolette and Wainwright, Claire (2007). Fosfomycin – Investigation of a possible new route of administration of an old drug: A case study. Journal of Cystic Fibrosis, 6 (3), 244-246. doi: 10.1016/j.jcf.2006.08.003

Smith, Lucas, Rose, Barbara, Tingpej, Pholawat, Zhu, Hua, Conibear, Tim, Manos, Jim, Bye, Peter, Elkins, Mark, Willcox, Mark, Bell, Scoot, Wainwright, Claire and Harbour, Colin (2006). Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis. Journal of Medical Microbiology, 55 (12), 1641-1644. doi: 10.1099/jmm.0.46845-0

Thomas, Clare, Mitchell, Penny, O'Rourke, Peter and Wainwright, Claire (2006). Quality-of-life in children and adolescents with cystic fibrosis managed in both regional outreach and cystic fibrosis center settings in Queensland. Journal Of Pediatrics, 148 (4), 508-516. doi: 10.1016/j.jpeds.2005.11.040

Murphy, A. J., Buntain, H. M., Wainwright, C. E. and Davies, P. S. W. (2006). The nutritional status of children with cystic fibrosis. British Journal of Nutrition, 95 (2), 321-324. doi: 10.1079/BJN20051611

Buntain, H. M., Schluter, P. J., Bell, S. C., Greer, R. M., Wong, J. C. H., Batch, J., Lewindon, P. and Wainwright, C. E. (2006). Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax, 61 (2), 146-154. doi: 10.1136/thx.2005.046516

Elkins, Mark R., Robinson, Michael, Rose, Barbara R., Harbour, Colin, Moriarty, Carmel P., Marks, Guy B., Belousova, Elena G., Xuan, Wei, Bye, Peter T. P., for the National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group and Wainwright, C. (2006). A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. New England Journal of Medicine, 354 (3), 229-240. doi: 10.1056/NEJMoa043900

Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients. Clinical Pharmacokinetics, 45 (11), 1099-1114. doi: 10.2165/00003088-200645110-00004

Cheney, Joyce, Barber, Scott, Altamirano,Luis, Cheney, Marise, Williams, Chris, Jackson, Mary, Yates, Patsy, O'Rourke, Peter and Wainwright, Claire (2005). A clinical pathway for bronchiolitis is effective in reducing readmission rates. The Journal of Pediatrics, 147 (5), 622-626. doi: 10.1016/j.jpeds.2005.06.040

Chandan, Snehal S., Faoagali, Joan and Wainwright, Claire E. (2005). Sensitivity of respiratory bacteria to lignocaine. Pathology, 37 (4), 305-307. doi: 10.1080/00313020500168752

Buntain, Helen M., Greer, Ristan M., Wong, Joseph C.H., Schluter, Philip J., Batch, Jennifer, Lewindon, Peter, Bell, Scott C. and Wainwright, Claire E. (2005). Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis. Journal of Paediatrics And Child Health, 41 (7), 317-322. doi: 10.1111/j.1440-1754.2005.00635.x

Massie, J, Clements, B, Australasian Paediatric Respiratory Group and Wainwright, Claire (2005). Diagnosis of cystic fibrosis after newborn screening: The Australasian experience - Twenty years and five million babies later: A consensus statement from the Australasian Paediatric Respiratory Group. Pediatric Pulmonology, 39 (5), 440-446. doi: 10.1002/ppul.20191

Murphy, A. J., Buntain, H., White, M., Wainwright, C., Lockwood, L. and Davies, P. S. W. (2005). Body cell mass adjustment for stature in children with clinical conditions. International Journal of Body Composition Research, 3 (3), 101-101.

Redmann, S, Wainwright, C, Stacey, S, Champion, A, Mitchell, P, Cheney, J and Charles, B (2005). Misleading high tobramycin plasma concentrations can be caused by skin contamination of fingerprick blood following inhalation of nebulized tobramycin (TOBI (R)) - A short report. Therapeutic Drug Monitoring, 27 (2), 205-207. doi: 10.1097/01.ftd.0000155341.16361.62

Puiman, P. J., Francis, P., Buntain, H., Wainwright, C., Masters, B. and Davies, P. S. W. (2004). Total body water in children with cystic fibrosis using bioelectrical impedance. Journal of Cystic Fibrosis, 3 (4), 243-247. doi: 10.1016/j.jcf.2004.06.007

Syrmis, Melanie W., O'Carroll, Mark R., Sloots, Theo P., Coulter, Chris, Wainwright, Claire E., Bell, Scott C. and Nissen, Michael D. (2004). Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-element-based PCR assays. Journal of Medical Microbiology, 53 (11), 1089-1096. doi: 10.1099/jmm.0.45611-0

Greer, Ristan M., Buntain, Helen M., Lewindon, Peter J., Wainwright, Claire E., Potter, Julia M., Wong, Joseph C., Francis, Paul W., Batch, Jennifer A. and Bell, Scott C. (2004). Vitamin A levels in patients with CF are influenced by the inflammatory response. Journal of Cystic Fibrosis, 3 (3), 143-149. doi: 10.1016/j.jcf.2004.04.003

O'Carroll, M. R., Syrmis, M. W., Wainwright, C. E., Greer, R. M., Mitchell, P., Coulter, C., Sloots, T. P., Nissen, M. D. and Bell, S. C. (2004). Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. European Respiratory Journal, 24 (1), 101-106. doi: 10.1183/09031936.04.00122903

Murphy, A. J., Buntain, H. M., Wong, J. C. H., Greer, R. M., Wainwright, C. E. and Davies, P. S. W (2004). The use of air displacement plethysmography in children and adolescents with cystic fibrosis. European Journal of Clinical Nutrition, 58 (7), 985-989. doi: 10.1038/sj.ejcn.1601919

Doring, Gerd, Hoiby, Niels, Wainwright, Claire and Consensus Study Group (2004). Early intervention and prevention of lung disease in cystic fibrosis: a European consensus*1. Journal of Cystic Fibrosis, 3 (2), 67-91. doi: 10.1016/j.jcf.2004.03.008

Buntain, HM, Greer, RM, Schluter, PJ, Wong, JCH, Batch, JA, Potter, JM, Lewindon, PJ, Powell, E, Wainwright, CE and Bell, SC (2004). Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax, 59 (2), 149-155. doi: 10.1136/thorax.2003.006726

Wainwright, Claire and Francis, Paul (2003). Treatment of Bronchiolitis. New England Journal of Medicine, 349 (14), 1384-1385.

Wainwright, C., Altamirano, L., Cheney, M., Cheney, J., Barber, S., Price, D. A., Moloney, S. E., Kimberley, A., Woolfield, N., Cadzow, S., Fiumara, F., Wilson, P., Mego, S., VandeVelde, D. and Sanders, S. L. (2003). A multicentre, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. New England Journal of Medicine, 349 (1), 27-35. doi: 10.1056/NEJMoa022226

Armstrong, David, Bell, Scott, Robinson, Michael, Bye, Peter, Rose, Barbara, Harbour, Colin, Lee, Crystal, Service, Helen, Nissen, Michael, Syrmis, Melanie and Wainwright, Claire (2003). Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. Journal of Clinical Microbiology, 41 (5), 2266-2267. doi: 10.1128/JCM.41.5.2266-2267.2003

Wainwright, C and Wootton, R (2003). A review of telemedicine and asthma. Disease Management & Health Outcomes, 11 (9), 557-563. doi: 10.2165/00115677-200311090-00003

Greer, Ristan M., Buntain, Helen M., Potter, Julia M., Wainwright, Claire E., Wong, Joseph C., O'Rourke, Peter K., Francis, Paul W., Bell, Scott C. and Batch, Jennifer A. (2003). Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls. Osteoporosis International, 14 (5), 404-411. doi: 10.1007/s00198-003-1388-1

Nixon, G. M., Armstrong, D. S., Carzino, R., Carlin, J. B., Olinsky, A., Robertson, C. F., Grimwood, K. and Wainwright, C. (2002). Early airway infection, inflammation, and lung function in cystic fibrosis. Archives of Disease in Childhood, 87 (4), 306-311. doi: 10.1136/adc.87.4.306

Masters, IB, Chang, AB, Patterson, L, Wainwright, C, Buntain, H, Dean, BW and Francis, PW (2002). Series of laryngomalacia, tracheomalacia, and bronchomalacia disorders and their associations with other conditions in children. Pediatric Pulmonology, 34 (3), 189-195. doi: 10.1002/ppul.10156

Buntain, H. M., Gréer, R., Wainwright, C., Batch, J. and Bell, S. (2001). Vitamin D status and bone mineral density in an australian cystic fibrosis population. Respirology, 6 (SUPPL. 1).

Isles, A. F., Wainwright, C. and Banks, E. (2000). Current issues in childhood asthma (Part 1). Medicine Today, 1 (2), 46-57.

Isles, A. F., Wainwright, C. and Banks, E. (2000). Current issues in childhood asthma (part 2). Medicine Today: the peer reviewed journal of clinical practice, 1 (2), 62-67.

Nixon, G., Wainwright, C., Armstrong, D., Carzino, R., Grimwood, K. and Robertson, C. (1999). The influence of pulmonary infection on lung function in infants with cystic fibrosis. Respirology, 4 (SUPPL. 1).

Wainright, C. and Isles, A. F. (1999). Respiratory emergencies in children. Modern Medicine of Australia, 42 (1), 12-20.

Francis, Paul and Wainwright, Claire (1997). The wheezing infant. Current Therapeutics, 38 (10), 41-46.

Wainwright, C, Isles, AF and Francis, PW (1997). MJA practice essentials .8. Asthma in children. Medical Journal of Australia, 167 (4), 218-223.

Wainwright, C., Isles, A. F. and Francis, P. W. (1997). MJA practice essentials - Respiratory medicine. 8. Asthma in children. Medical Journal of Australia, 167 (4), 218-223. doi: 10.5694/j.1326-5377.1997.tb138856.x

Thomson, MA, Wilmott, RW, Wainwright, C, Masters, B, Francis, PJ and Shepherd, RW (1996). Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis. Journal of Pediatrics, 129 (3), 367-373. doi: 10.1016/S0022-3476(96)70068-9

Stockwell, R., Leong, L., Wheeler, N., Bryant, J., Wood, M., Sherrard, L., Thomson, R., Carter, R., Tolson, C., Rogers, G., Wainwright, C., Parkhill, J., Floto, R. and Bell, S. (2020). Alternative transmission pathways of mycobacterium abscessus group (MABs) respiratory infections. TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Melbourne, VIC Australia, 27–31 March 2020. Richmond, VIC Australia: Wiley-Blackwell.

Taylor, S., Leong, L., Ivey, K., Wesselingh, S., Grimwood, K., Wainwright, C. and Rogers, G. (2020). How lung microbiology relates to structural disease in paediatric cystic fibrosis: total abundance trumps infective species. TSANZ20, Melbourne, VIC, Australia, 27-31 March 2020. Hoboken, NJ, United States: John Wiley & Sons.

Wainwright, C., Flume, P., Biner, Fischer R., Downey, D., Brown, C., Jain, M., Fischer, R., De Boeck, K., Campbell, D., Wang, X., Ahluwalia, N. and Owen, C. (2020). Open-label extension study: tezacaftor/ivacaftor, patients >= 12 years with cystic fibrosis. TSANZ20, Melbourne, VIC, Australia, 27-31 March 2020. Hoboken, NJ, United States: John Wiley & Sons.

Duplancic, C., Thomson, R., Wainwright, C. and Bell, S. C. (2019). High incidence of non-tuberculous mycobacteria-positive cultures among children with cystic fibrosis in Australia. Unknown, Unknown, Unknown. Hoboken, NJ USA: John Wiley & Sons.

Acaster, S., Mukuria, C., Rowen, D., Brazier, J., Wainwright, C., Quon, B., Duckers, J., Quittner, A. L., Lou, Y., Sosnay, P. and McGarry, L. (2019). Development of the cystic fibrosis questionnaire-revised preference based scoring algorithm. Annual North American Cystic Fibrosis Conference, Nashville, TN, United States, 31 October - 2 November 2019. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/ppul.22495

Stockwell, R. E., Thomson, R., Leong, L. E., Wheeler, N. E., Bryant, J., Wood, M. E., Sherrard, L. J., Carter, R., Tolson, C., Rogers, G., Wainwright, C., Parkhill, J., Floto, R. A. and Bell, S. C. (2019). Mycobacterium abscessus point source outbreak in the local potable water supply affecting people with cystic fibrosis. Annual North American Cystic Fibrosis Conference, Nashville, TN, United States, 31 October - 2 November 2019. Hoboken, NJ, United States: John Wiley & Sons.

Stockwell, R., Wood, M., Moore, , Wainwright, C. and Bell, S. (2019). Infection control practices used in cystic fibrosis centres in Australia and New Zealand. TSANZ, Gold Coast, QLD, Australia, 29 March-2 April 2019. Hoboken, NJ, United States: John Wiley & Sons.

Duplancic, C., Wainwright, C., Thomson, R. and Bell, S. (2019). Non-tuberculous mycobacteria infection in people with cystic fibrosis attending cf treatment clinics in Australia. TSANZ, Gold Coast, QLD, Australia, 29 March-2 April 2019. Hoboken, NJ, United States: John Wiley & Sons.

Wainwright, C., Tarique, A., Sly, P., Bell, S. and Fantino, E. (2019). Modulation of macrophage polarization and function in patients with cystic fibrosis by mutation-independent immunomodulatory compounds. TSANZSRS 2019 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting, Gold Coast, Australia, 29 March–2 April 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.13492

Morshed, M., Tarique, A., Sly, P., Bell, S., Wainwright, C. and Fantino, E. (2019). Kinetic expression of genes and receptors during monocyte to macrophage differentiation in cystic fibrosis. TSANZSRS 2019 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting, Gold Coast, Australia, 29 March–2 April 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.13492

Yeo, Abrey Jie, Fantino, Emmanuelle, Wainwright, Claire, Sinclair, Kate and Lavin, Martin Francis (2018). Role of oxidative stress in pulmonary disease in ataxia-telangiectasia. Ataxia Telangiectasia Clinical Research Conference , Naples, Italy, 29 November-1 December 2018.

Stockwell, R. E., Leong, L., Wood, M. E., Sherrard, L., Carter, R., Tolson, C., Thomson, R., Rogers, G., Wainwright, C. and Bell, S. C. (2018). Potable water as a possible source of mycobacterium abscessus complex infection in people with cystic fibrosis. Annual North American Cystic Fibrosis Conference, Denver, CO, United States, 18-20 October 2018. Hoboken, NJ, United States: John Wiley & Sons.

Strachan, R., Beggs, S., Fearon, D., Gilbert, G., Homaira, N., Lambert, S., Marshall, H., Martin, A., McCallum, G., McCullagh, A., McDonald, T., Mcintyre, P., Oftadeh, S., Ranganathan, S., Suresh, S., Teoh, L., Twaij, A., Wainwright, C., Wong, M., Snelling, T. and Jaffe, A. (2018). The impact of the 13 valent conjugate pneumococcal vaccine on pneumococcal serotypes causing childhood empyema in Australia. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting, Adelaide, Australia, 23–27 March 2018. Hoboken, NJ United States: Wiley.

Flume, Patrick A., Wainwright, Claire E., Tullis, D. Elizabeth, Rodriguez, Sally, Niknian, Minoo, Higgins, Mark, Davies, Jane C. and Wagener, Jeffrey S. (2018). Recovery of lung function following a pulmonary exacerbation in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor. 36th Conference of the European-Cystic-Fibrosis-Society (ECFS), Lisbon, Portugal, 12-15 June 2013. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jcf.2017.06.002

Yeo, AJ, Fantino, E, Sly, PD, Wainwright, Claire, Krause, L, Sinclair, K and Lavin, Martin Francis (2017). Role of oxidative stress in pulmonary disease in ataxia-telangiectasia.. Ataxia Telangiectasia Workshop ATW 2017, Milan, Italy, 20-24 March 2017.

Stockwell, R. E., Johnson, G., Ramsay, K., Sherrard, L. J., Jabbour, N., Knibbs, L. D., Kidd, T. J., Wainwright, C. E., Morawska, L. and Bell, S. C. (2017). Face masks and cough etiquette reduce cough generated bioaerosols containing Pseudomonas aeruginosa in patients with cystic fibrosis. The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting, Canberra, ACT, Australia, 24–28 March 2017. Richmond, VIC, Australia: John Wiley & Sons.

Yeo, AJ, Fantino, E, Sly, PD, Wainwright, C, Krause, L, Sinclair, K and Lavin, Martin Francis (2016). Pulmonary disease in ataxia-telangiectasia. Ataxia Telangiectasia Clinical Research Conference, Warsaw, Poland, 4-6 October 2016.

McNally, P. G., O'Rourke, J., Fantino, E., Chacko, A., Pabary, R., Turnbull, A., Wainwright, C. E., Linnane, B., Davies, J. C. and Sly, P. (2016). Pooling of Bronchoalveolar Lavage in Children with Cystic Fibrosis Does Not Affect the Microbiological Yield and May Allow Earlier Detection of Pulmonary Inflammation. The 30th Annual North American Cystic Fibrosis Conference, Orlando, Florida, United States, October 27–29, 2016. Hoboken, United States: John Wiley & Sons. doi: 10.1002/ppul.23576

Wood, M. E., Stockwell, R., Johnson, G., Ramsay, K., Sherrard, L., Jabbour, N., Knibbs, L., Kidd, T., Wainwright, C. E., Morawska, L. and Bell, S. C. (2016). Face masks and cough etiquette reduce cough-generated bioaerosols containing pseudomonas aeruginosa in patients with cystic fibrosis. The 30th Annual North American Cystic Fibrosis Conference, Orlando, FL, United States, 27-29 October 2016. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/ppul.23576

De Boeck, K., Elborn, J., Ramsey, B., Boyle, M. P., Konstan, M. W., Huang, X., Marigowda, G., Waltz, D. and Wainwright, C. E. (2015). Efficacy and safety of lumacaftor plus ivacaftor combination therapy in patients with CF homozygous for f508del-cftr by fev1 subgroups. Annual North American Cystic Fibrosis Conference, Bethesda, MD, United States, 8-10 October 2015. Hoboken, NJ, United States: John Wiley & Sons.

McColley, S. A., Konstan, M. W., Ramsey, B. W., Elborn, J., Boyle, M. P., Wainwright, C. E., Waltz, D., Vera-Llonch, M., Jiang, J. and Rubin, J. (2015). Association between changes in percent predicted fev1 and incidence of pulmonary exacerbations, including those requiring hospitalization and/or iv antibiotics, in patients with CF treated with lumacaftor in combination with ivacaftor. Annual North American Cystic Fibrosis Conference, Phoenix, AZ, United States, 8-10 October 2015. Hoboken, NJ, United States: John Wiley & Sons.

Konstan, M. W., Ramsey, B. W., Elborn, J., Boyle, M. P., Waltz, D., Marigowda, G., Nair, N. and Wainwright, C. E. (2015). Safety and efficacy of treatment with Lumacaftor in combination with Ivacaftor in patients with Cf homozygous for F508Del-Cftr. Annual North American Cystic Fibrosis Conference, Bethesda, MD, United States, 8-10 October 2015. Hoboken, NJ, United States: John Wiley & Sons.

Chacko, A., Wainwright, C., Sly, P., Davies, J., Linnane, B. and Mcnally, P. (2015). Pooling of Bronchoalveloar Lavage Samples Affects Microbiology Results in Children. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting 2015, Gold Coast, Queensland, Australia, 27 March – 1 April 2015. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Harun, S., Wainwright, C. and Hennig, S. (2015). Predictive factors of probability of having Aspergillus fumigatus positive culture in bronchoalveolar lavage culture at five years of age of children with cystic fibrosis. Joint ASCEPT-APSA 2015, Hobart, TAS, Australia, 29 November – 2 December 2015.

Harun, S., Wainwright, C., Holford, N. H. G. and Hennig, S. (2015). The hazard of Aspergillus fumigatus positive culture in young children with cystic fibrosis. Children’s Health Queensland Research Day, Brisbane, QLD, Australia, December 2015.

Wainwright, C., Bell, S., Morton, J., Ryan, G., Serisier, D., Bye, P., Mulrennan, S., Daley, C. and Greville, H. (2014). The Effect of Ivacaftor in Individuals with Cystic Fibrosis and Severe Lung Disease: Analysis of Data From the Australian Named Patient Programme. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_10

Kidd, T. J., Knibbs, L. D., Johnson, G., Kattenbelt, J. A., Ramsay, K. A., Wood, M., Beevers, A., O'Rourke, P. K., Wainwright, C. E., Grimwood, K., Sly, P., Morawska, L. and Bell, S. C. (2013). Viability of pseudomonas aeruginosa (Pa) in cough aerosols from adult cystic fibrosis (CF) patients. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2013 Annual Scientific Meetings, Darwin, NT Australia, 22-27 March 2013. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/resp.12045

Roehrer, Erin, Cummings, Elizabeth, Turner, Paul, Hauser, Jenny, Cameron-Tucker, Helen, Beggs, Sean A., Micallef, Nicole A., Wainwright, Claire, Cheney, Joyce, Jessup, Mel, Saddington, Heather, Ellis, Leonie, Walters, Haydn and Reid, David W. (2013). Supporting cystic fibrosis with ICT. ITCH 2013, Laurel Point, Victoria, BC, Canada, 21-23 February 2013. Amsterdam, Netherlands: IOS Press. doi: 10.3233/978-1-61499-203-5-137

Wainwright, Claire E. (2013). Puberty in Cf. The 27th Annual North American Cystic Fibrosis Conference, Salt Lake City, Utah, 17 -19 October 2013. Hoboken, NJ United States: John Wiley and Sons Inc.. doi: 10.1002/ppul.22896

Smith, D., Kidd, T. J., Ramsay, K. A., Wainwright, C. E., Grimwood, K. and Bell, S. C. (2012). Pseudomonas aeruginosa resistance: Comparison between Australian cystic fibrosis (cf) centres. unknown, unknown, unknown. Richmond, VIC, Australia: John Wiley and Sons.

Kidd, T. J., Ramsay, K. A., Hu, H., Bye, P. T. P., Elkins, M. R., Marks, G. B., Wainwright, C. E., Robinson, P. J., Grimwood, K., Bell, S. C. and ACPINCF Investigator Study Grp (2012). Heterogeneity of shared P. Aeruginosa (pa) strains across states and centres in cystic fibrosis. unknown, unknown, unknown. Richmond, VIC, Australia: John Wiley and Sons.

Byrnes, C. A., Vidmar, S., Cheney, J. and Wainwright, C. E. (2012). Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age (for ACFBAL Study Group). 26th Annual North American Cystic Fibrosis Conference, Orlando, FL, United States, 11-13 October 2012. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/ppul.22682

Hanks-Thomson, Kirstin R., Kidd, Timothy J., Wainwright, Claire E., Ramsey, Kay A., Steen, Jason A., Bell, Scott C., Zakour, Nouri L. Ben and Beatson, Scott A. (2012). Acquired aminoglycoside resistance in pseudomonas aeruginosa from a cystic fibrosis patient. Australian Society for Microbiology Annual Scientific Meeting (ASM2012), Brisbane, Australia, 1-4 July 2012.

Ramsay, K. A., Butler, C., Kidd, T. J., Wainwright, C. E. and Bell, S. C. (2012). Burkholderia cepacia complex infection (bcc) in cystic fibrosis (cf): 2001-2010. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2012 Annual Scientific Meetings, Canberra ACT, Australia, 30 March-4 April 2012. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2012.02143.x

Kirstin R. Hanks-Thomson, Timothy J. Kidd, Jason A. Steen, Claire E. Wainwright, Keith Grimwood, Scott C. Bell, Nouri L. Ben Zakour, Barbara Rose, Jim Manos, Nicola K. Petty and Scott A. Beatson (2011). Genetic adaptation of Pseudomonas aeruginosa to the airways of two Australian cystic fibrosis patients. Pseudomonas 2011, Sydney, 4-9-2011 to 7-9-2011. Sydney: University of Technology - Sydney (UTS).

Timothy Kidd, Kay Ramsay, Bell, Scott C., Claire Wainwright and Keith Grimwood (2011). Australasian CF bronchoalveolar lavage (ACFBAL) Study: Pseudomonas aeruginosa (Pa) genotypes in pre-school CF children. 9th Australasian Cystic Fibrosis Conference, Melbourme, Australia, 20 - 23rd August 2011.

Timothy Kidd, Kay Ramsay, He Hu, Bye P, Elkins M, Marks G, Claire Wainwright, robinson P, Rose B, Harbour C, Keith Grimwood, Bell, Scott C. and ACPinCF Investigator Study Group (2011). Widespread prevalence of related Pseudomonas aeruginosa strains within Australian cystic fibrosis centres. 9th Australasian Cystic Fibrosis Conference, Melbourne , Australia, 20-23 August 2011.

Smith DJ, Timothy Kidd, Kay Ramsay, Keith Grimwood, Claire Wainwright and Bell, Scott C. (2011). Pseudomonas aeruginosa antibiotic resistance: comparison between Australian paediatric and adult cystic fibrosis centres. 9th Australasian Cystic Fibrosis Conference, Melbourme, Australia, 20-23rd August 2011.

He Hu, Anuj S, Claire Wainwright, Whitechurch C, Harmer C, Joyce Cheney, Turnbull L, Manos J, Keith Grimwood, Bye P, Rose B and and the ACFBAL study investigators (2011). Environmental origins of Pseudomanos aeruginosa in children with cystic fibrosis. 13th International Conference on Pseudomonas, Sydney , Australia, 4-7th September 2011.

He Hu, Rose B, Claire Wainwright, Whitechurch C, Elkins M, Bye P, Harmer C, Joyce Cheney, Turnbull L, Keith Grimwood, Manos J and and the ACFBAL study investigators (2011). Loss of virulence expression of pseudomonas aeruginosa from cystic fibrosis lung infection over time. 13th International Conference on Pseudomonas, Sydney , Australia, 4-7 September 2011.

Wainwright, CE, Kidd, TJ, Ramsey, KA, Bell, SC and Grimwood, K (2011). Australasian Cf Bronchoalveolar Lavage (acfbal) Study: P. Aeruginosa (pa) Genotypes in Pre-School Cf Children. Unknown, unknown, unknown. MALDEN: WILEY-BLACKWELL.

Jessup, M. M., Cameron-Tucker, H., Cummings, E., Hauser, J., Joseph, L., Saddington, H., Cheney, J., Turner, P., Wainwright, C. and Reid, D. W. (2010). ‘Someone to talk to’: adolescent and adult CF patients' feedback on their experience of a mentoring and IT intervention. 33rd European Cystic Fibrosis Conference, Valencia, Spain, 16-19 June 2010. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(10)60416-x

Kidd, T. J., Rainey, P. B., Ramsay, K. A., Grimwood, K., Wainwright, C. E. and Bell, S. C. (2010). Multilocus sequence typing (MLST) of Pseudomonas aeruginosa collected from different ecological niches. Australian Society for Microbiology 51st Scientific Meeting, Sydney, NSW, Australia, 4-8 July 2010.

Kidd, T. J., Rainey, P. B., Ramsay, K. A., Grimwood, K., Wainwright, C. E. and Bell, S. C. (2010). Multilocus sequence typing (MLST) of Pseudomonas aeruginosa. Thoracic Society of Australia and New Zealand Annual Scientific Meeting, Brisbane, Qld Australia, 20-24 March 2010.

Kidd, T. J., Ramsay, K. A., Hu, H., Bye, P. T. P., Marks, G. B., Wainwright, C. E., Robinson, P. J., Rose, B. R., Harbour, C., Grimwood, K., Bell, S. C. and ACPinCF Investigator Study Group (2010). Clonal pseudomonas aeruginosa (PA) in Australians with cystic fibrosis (CF). Thoracic Society of Australia and New Zealand Annual Scientific Meeting, Brisbane, QLD Australia, 20-24 March 2010.

Kidd, T. J., Rainey, P. B., Ramsay, K. A., Grimwood, K., Wainwright, C. E. and Bell, S. C. (2010). Multilocus sequence typing (MLST) of Pseudomonas aeruginosa collected from different ecological niches. 33rd European Cystic Fibrosis Conference, Valencia, Spain, 16-19 June 2010. Amsterdam: Elsevier Science. doi: 10.1016/S1569-1993(10)60114-2

Bell, S. C., Grimwood, K., Hargreaves, M., Kidd, T. J., Nissen, M. D., Rainey, P. B., Ramsey, K. A. and Wainwright, C. E. (2009). Comparison of multilocus sequence typing (MLST), pulse field gel electrophoresis (PFGE), and enterobacterial intergenic consenus PCR (ERIC) for the genotypic analysis of Pseudomonas aeruginosa isolates collected from persons with cystic fibrosis (CF). “Cystic Fibrosis – Finding A Balance”, Brisbane, 29 Aug - 1 Sep 2009. not available: not available.

Arshi, Mandana, Cardinal, John, Hill, Rebecca J., Davies, Peter S. W. and Wainwright, Claire E. (2009). Resistin and airway inflammation in children with allergic asthma. The Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2009 Annual Scientific Meetings, Darwin, NT, Australia, 3-8 April 2009. Carlton, VIC, Australia: Blackwell Science. doi: 10.1111/j.1440-1843.2009.01503_3.x

Truby, H., O'Neil, C., Victorsen, M. and Wainwright, C. (2007). The effect of gastrostomy feeding on markers of nutritional status in children with cystic fibrosis. The 21st North American Cystic Fibrosis Conference, Anaheim, Calafornia, 3-6th October 2007. U.S.A.: Wiley Liss.

Truby, Helen, Victorsen, Marie, O'Neil, Catherine and Wainwright, Claire (2007). The nutritional status of children with cystic fibrosis attending the Royal Children's Hospital in Queensland compared to data from the National CF Data Register. DAA 2007: Dietitians of Australia 25th National Conference, Hobart, Australia, 24-26 May 2007. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1747-0080.2007.00166.x

Wainwright, C., Carlin, J., Cooper, P., Byrnes, C., Martin, J., Grimwood, K., Armstrong, D., Francis, P., Dakin, C., Whitehead, B., Carter, R., Vidmar, S., Cheney, J., Tiddens, H., Fink, M. and Robertson, C. (2006). Australasian Cystic Fibrosis BAL Study Interim Analysis. 20th Annual North American Cystic Fibrosis Conference, Denver, Colorado, USA, 2-5 November 2006. doi: 10.1002/ppul.20538

Cheney, C. L., Carlin, J., Cooper, P., Byrnes, C., Grimwood, K., Armstrong, D., Martin, J., Dakin, C., Robertson, C., Whitehead, B., Francis, P., Vidmar, S. and Wainwright, C. (2006). Adverse events associated with flexible bronchoscopy (FB) and bronchoalveolar lavage (BAL) in young children with cystic fibrosis. 20th Annual North American Cystic Fibrosis Conference, Denver, Colorado, USA, 2-5 November 2006. New York, USA: Wiley. doi: 10.1002/ppul.20538

Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients. The 6th Annual Health and Medical Research Conference of Queensland, Brisbane, Australia, 23-24 November 2006. Brisbane, Australia: Queensland Health.

Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT). PAGANZ 06 9th Annual Scientific Meeting, Auckland New Zealand / School of Medicine, 7-9 February 2006. Brisbane, Australia: Poppulation Approach Group in Australia and New Zealand.

Hennig, S, Wainwright, C E, Bell, S, Miller, H, Charles, B G and Duffull, S B (2006). A D-optimal designed population pharmacokinetic study of itraconazole. APSA Annual Meeting 2006, Adelaide, Australia, 2-5 December 2006. Adelaide:

Hennig, S., Wainwright, C. E., Bell, S., Miller, H., Charles, B. G. and Duffull, S. B. (2006). A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis. 15th Annual Meeting of the Population Approach Group in Europe, Bruges, Belgium, 14-16 June 2006. PAGE.

Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients. Population Approach Group Europe: 15th Meeting, Bruges, Belgium, 14-16 June 2006. PAGE.

Wainwright, C. E., Carlin, J. B., Cooper, P., Byrnes, C., Martin, J., Grimwood, K., Armstrong, D., Francis, P., Dakin, C., Whitehead, B., Carter, R., Vidmar, S., Cheney, J., Robertson, C. and on behalf of the ACFBAL study group (2005). Adverse events associated with flexible bronchoscopy (FB) and bronchoalveolar lavage (BAL) in young children with cystic fibrosis. 6th Australian and New Zealand Cystic Fibrosis Conference 2005, Adelaide, South Australia, 20-23 August, 2005.

Wainwright, C. E., Carlin, J. B., Cooper, P., Byrnes, C., Martin, J., Grimwood, K., Armstrong, D., Francis, P., Dakin, C., Whitehead, B., Carter, R., Vidmar, S., Cheney, J., Robertson, C. and on behalf of the ACFBAL study group (2005). Australasian Cystic Fibrosis BAL study interim analysis. 6th Australian and New Zealand Cystic Fibrosis Conference 2005, Adelaide, South Australia, 20-23 August, 2005.

Armstrong, D., Byrnes, C., Carlin, J., Cooper, P., Francis, P., Grimwood, K., Jones, A., McMorran, B., Robertson, C., Wainwright, B. and Wainwright, C. (2005). Proteomic investigations in the young CF lung: new insights into the inflammatory disorder. 6th Australian and New Zealand Cystic Fibrosis Conference 2005, Adelaide, South Australia, 20-23 August, 2005.

Syrmis, M., O'Carroll, M., Iredell, J., Wainwright, C., Coulter, C., Sloots, T., Bell, S. and Nissen, M. (2005). Detection of an integron associated aadB resistance gene in Pseudomonas aeruginosa isolates from patients with CF. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Syrmis, M., O'Carroll, M., Iredell, J., Wainwright, C. E., Coulter, C., Sloots, T., Bell, S. C. and Nissen, M. (2005). Detection of an integron associated aadb-resistance gene in Pseudomonas aeruginosa isolates from patients with CF. 28th European Cystic Fibrosis Conference, Crete, Greece, 22-25 Jun, 2005. Amsterdam, Netherlands: Elsevier BV.

Redmann, S., Stacey, S., Champion, A., Charles, B. G., Mitchell, P. and Wainwright, C. E. (2005). Misleading high tobramycin blood concentrations due to dermal contamination on fingers after inhalation of nebulised tobramycin (TOBI). 6th Australian and New Zealand Cystic Fibrosis Conference, Adelaide, South Australia, 20-23 August, 2005. Australia:

Buntain, H. M., Schluter, P. J., Greer, R. M., Wong, J., Bell, S., Lewindon, P., Batch, J. and Wainwright, C. E. (2005). Normal bone mass accrual in children and young people with cystic fibrosis - A longitudinal study. TSANZ 2005 Annual Scientific Meeting, Perth, Australia, 18-23 March 2005. Carlton South, Vic., Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00644.x

Batch, J., Bell, S., Buntain, H., Francis, P., Greer, R., Lewindon, P., Potter, J., Wainwright, C. and Wong, J. (2004). Vitamin A levels in patients with CF are influenced by the inflammatory response. Thoracic Society of Australia and New Zealand 2004 Annual Scientific Meeting, Sydney, Australia, 4 March, 2004. Blackwell.

Batch, J., Bell, S., Buntain, H., Francis, P., Greer, R., Lewindon, P., Wainwright, C. and Wong, J. (2004). Normal fat and lean tissue mass in adults with cystic fibrosis compared with height matched controls. Thoracic Society of Australia and New Zealand 2004 Annual Scientific Meeting, Sydney, Australia, 4 March, 2004. Blackwell.

Redmann, S., Stacey, S., Champion, A., Wainwright, C. E., Mitchell, P., Cheney, J. and Charles, B. G. (2004). Misleading high tobramycin plasma concentrations due to dermal contamination on fingers after inhalation of nebulised tobramycin (TOBI). 4th Annual Queensland Health and Medical Scientific Meeting, Brisbane, 30 November - 1 December, 2004. Brisbane: Queensland Government.

Redmann, S., Stacey, S., Champion, A., Wainwright, C. E. and Mitchell, P. (2004). Misleading high tobramycin blood levels due to dermal contamination on fingers after inhalation of TOBI. SHPA Qld Branch Conference, Toowoomba, 16-18 July, 2004. Australia: SHPA.

Greer, R., Buntain, H. M., Wainwright, C. E., Batch, J. A., Francis, P. W. and Bell, S. C. (2003). Vitamin A is associated with the inflammatory marker CRP in cystic fibrosis. 26th Congress of the European Cystic Fibrosis Society, Belfast, Ireland, 5 Jun, 2003. Amsterdam: Elsevier BV. doi: 10.1016/j.jcf.2004.06.005

O'Carroll, M. R., Bell, S. C., Coulter, C., Wainwright, C. E., Nissen, M., Sloots, T. and Syrmis, M. (2003). Rapid genotyping of Pseudomonas aeruginosa using repetitive element based PCr assays. TSANZ 2003 Annual Scientific Meeting, Adelaide, Australia, 4-9 April, 2003. Carlton South, Australia: doi: 10.1111/j.1440-1843.2003.supp_1.x

O'Carroll, M. R., Bell, S. C., Coulter, C., Wainwright, C. E., Nissen, M., Sloots, T. and Syrmis, M. (2003). Presence of epidemic Pseudomonas aeruginosa shared between paediatric and adult cystic fibrosis. TSANZ 2003 Annual Scientific Meeting, Adelaide, Australia, 4-9 April, 2003. Carlton South, Australia: doi: 10.1111/j.1440-1843.2003.supp_1.x

O'Carroll, M. R., Coulter, C., Bell, S. C., Syrmis, M., Wainwright, C. E., Nissen, M. and Sloots, T. (2003). Rapid genotyping of Pseudomonas aeruginosa using repetitive element based PCR assays. 26th European CF Conference, Belfast, Ireland, 5–7 June , 2003. Netherlands: Elsevier Science. doi: 10.1016/S1569-1993(03)00027-4

O'Carroll, M. R., Coulter, C., Bell, S. C., Syrmis, M., Wainwright, C. E., Nissen, M. and Sloots, T. (2003). Presence of epidemic Pseudomonas aeruginosa shared between paediatric and adult cystic fibrosis. 26th European CF Conference, Belfast, Ireland, 5–7 June , 2003. Netherlands: Elsevier Science. doi: 10.1016/S1569-1993(03)00027-4

Buntain, H. M., Greer, R. M., Batch, J., Wong, J., Lewindon, P., Schluter, P., Bell, S. C., Potter, J. and Wainwright, C. E. (2002). Puberty and bone mineral accrual in cystic fibrosis. TSANZ 2002 Annual Scientific Meeting. Respirology, Cairns, QLD, Australia, 22-27 March 2002. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2004.supp_2.x

Greer, R., Buntain, H., Wainwright, C., Wong, J., Lewindon, P., Potter, J., Francis, P., O'Rourke, P., Munns, C., Batch, J. and Bell, S. (2002). Calcium homeostasis in patients with cystic fibrosis. TSANZ Annual Scientific Meeting, Cairns, QLD, Australia, 22-27 March 2002. Carlton, VIC, Australia: Blackwell Asia. doi: 10.1111/j.1440-1843.2004.supp_2.x

Greer, R. M., Buntain, H., Wainwright, C. E., Potter, J. M., Munns, C., O'Rourke, P., Francis, P., Batch, J. and Bell, S. C. (2002). Uncoupled bone turnover in cystic fibrosis: bone markers and the PTH-vitamin D axis. 16th Annual North American Cystic Fibrosis Conference, Louisiana, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70012

Buntain, H., Greer, R. M., Schluter, P., Batch, J., Bell, S. C. and Wainwright, C. E. (2002). Age appropriate pubertal development in cystic fibrosis. The 16th Annual North American Cystic Fibrosis Conference, Louisiana, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70012

Davies, P. S. W., Buntain, H. M., Wong, J. C. H., Greer, R. M., Wainwright, C. and Murphy, A. J. (2002). The use of air displacement in plethysmography to measure fat free mass in children. The Sixth International Symposium "In Vivo Body Composition Studies", Rome, Italy, 3-5 October, 2002. Milan, Italy: Springer International. doi: 10.1007/s005920200032

Murphy, A. J., Buntain, H. M., Wong, J. C. H., Greer, R. M., Wainwright, C. and Davies, P. S. W. (2002). Body composition assessment in children with cystic fibrosis using air displacement plethysmography. The Sixth International Symposium "In Vivo Body Composition Studies", Rome, Italy, 3-5 October 2002. Milan, Italy: Springer. doi: 10.1007/s005920200032

Nixon, G., Wainwright, C., Armstrong, D., Carzino, R., Grimwood, K. and Robertson, C. (1999). The influence of pulmonary infection on lung function in infants with cystic fibrosis. Unknown, Unknown, Unknown. New York, NY USA: American Thoracic Society.

Strachan, Roxanne E., Gulliver, T., Martin, A., McDonald, T., Nixon, G., Roseby, V., Ranganathan, V., Selvadurai, H., Smith, G., Suresh, S., Teoh. L., Twiss, J., Wainwright, C. and Jaffé, Adam (2011). Paediatric empyema thoracis: Recommendations for management. Sydney, Australia: Thoracic Society of Australia and New Zealand..

Professor Claire Wainwright

Publications

Book Chapters

Journal Articles

Conference Papers

Research Report